Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City
PRINCETON, N.J., July 10 /PRNewswire-FirstCall/ -- Medarex, Inc.
(Nasdaq: MEDX ) today provided a detailed overview of the company's
strategy, strength in research discovery and antibody development, and the
multiple opportunities Medarex is engaged in for creating long-term value.
AIDS Action Council Statement on World AIDS Day 2007: Leadership Needed for a National Strategy to Stop the AIDS Epidemic
WASHINGTON, Nov. 29 /PRNewswire-USNewswire/ -- AIDS Action Council
joins organizations and individuals across the country and around the world
in observing the 20th annual World AIDS Day, December 1, 2007. Since 1988,
World AIDS Day
has provided countless opportunities to raise awareness
World AIDS Day Audio Press Conference
Thursday, November 29, 2007
10:00 a.m. (EST)
A World AIDS Day
Call for Changes to PEPFAR's HIV Prevention Strategies
Leading U.S. and African Women's, Faith-based and Youth Rights
Organizations Call on Congress to Start Taking Effective Prevention
Seriously in Reauthorization of Gl...
38.7 Million People Break Guinness World Record for Stand Up Speak Out on International Day for the Eradication of Poverty
Online press conference today with Mary Robinson, President, Realizing
Rights, the ethical global initiative, Salil Shetty (UNMC) and Kumi Naidoo
(GCAP) at 14.00GMT - log on at http://www.standagainstpoverty.org/press/conference
NEW YORK, Oct. 18 /PRNewswire-USNewswire/ -- Over 38.7 millio...
Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day
Pivotal Trial Expected to Initiate in 2010 for Blinatumomab
NEW YORK, April 24 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI ), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today held an R&am...
Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day
- Focalin XR demonstrated better symptom control versus Concerta from 30 minutes to six hours post-dose in primary and secondary endpoints
- Only Focalin XR provided onset of effect as early as 30 minutes post-dose
- Additional analysis suggests Focalin XR provides comparable efficacy to ...
Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day
MONTVALE, N.J., May 16 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals
Corp. (Nasdaq: MEMY ) today announced progress with several key development
programs at its R&D Day
meeting with the investment community. The Company
reported new clinical data for MEM 1414, its lead PDE4 inhibitor,
Award-Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec. 1 for 24-hour Vigil Recognizing World AIDS Day
Water bearers from Fort Point Channel to the Cyclorama mark 16th Annual
BOSTON, Nov. 15 /PRNewswire-USNewswire/ -- Artist Michael Dowling is
inviting thousands of youth to process with black and copper buckets filled
with water from Fort Point Channel in South Boston into The B...
European Experts Recommend Pregnant and Nursing Women Take More DHA - Every Day
Women Who Take DHA Have Healthier Pregnancies, Fewer Premature Births
GORDONSVILLE, Va., Aug. 29 /PRNewswire/ -- More than 50 nutritional
experts from a European Union (EU) committee now recommend pregnant and
nursing women supplement their diets on a daily basis with a large amount
of DHA, a...
Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm
Formation in 21 Day Study
DENVER--(BUSINESS WIRE)--Mar 12, 2007 - Ceragenix Pharmaceuticals,
Inc. (OTCBB:CGXP), a biopharmaceutical company focused on
infectious disease and dermatology, today announced that a catheter
treated with a Ceragenin compound demonstrated virtually no biofilm
formation in a 21 day
In the s...
New Data Shows Once a Day Lamictal XR is Effective in Treating
Patients with Partial Seizures
Data Presented at the American Academy of Neurology Annual Meeting
Show Approximately 50 Percent Reduction in Partial Seizures
BOSTON, May 01, 2007 /PRNewswire/ -- Data from two clinical
trials presented today at the American Academy of Neurology (AAN)
meeting suggest that an investigational once ...
Radius' Investigational Bone Anabolic Agent, BA058, Increased Bone Mineral Density (BMD) at Key Fracture Sites in Phase 2 Clinical Trial in Postmenopausal Osteoporosis
...l supplementation requirements for osteoporosis of not less than 400 IU per day
of Vitamin D and not less than 500 mg per day
of calcium, which continued throughout the study. Treatment was randomized ...
Project Zero Delay Accelerates Drug's Path to Clinical Trial
...ocol starts after IND approval. Zero Delay went from having a complete written protocol to first patient in 46 days, with FDA clearance of the IND on day
44. Research elsewhere cited in the Zero Delay paper indicates enrollment of the first patient after having a final protocol typically takes 3-6 mont...
Society of Gynecologic Oncologists Issues White Paper on HPV Vaccine's Impact on Cervical Cancer Prevention
...50 thought-leaders and cervical cancer experts from clinical, medical, epidemiology, regulatory and public health backgrounds. Sessions throughout the day
and a half meeting explored issues and concerns of public policy, clinical and cost effective issues surrounding the future of cervical cancer prevent...
Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
...(n=636). All patients received a dose of 234 mg on day
1 in the deltoid muscle. From day
8 and monthly thereafter, patients were assigned t...deltoid muscle one week apart (Day 1 at 234 mg and day
8 at 156 mg), followed by injections every month t...
Pharmasset Reports Positive Preliminary Antiviral Data With PSI-7851 for the Treatment of Hepatitis C
Dose N Mean Change in HCV RNA at day
Video: New Dove(R) Body Washes with NutriumMoisture(TM) Restore Skin's Natural Moisture
...rug, mass and club retailers. For more information visit dove.com .
The Dove mission is to make women feel more beautiful every day
by challenging today's stereotypical view of beauty and inspiring women to take great care of themselves. Dove, manufactured by Unilever, is the No. 1...
Octapharma Accepting Applications for Research Grants on Immunotherapy, Coagulation Disorders and Critical Care
... Octapharma USA , the Swiss company's rapidly-growing U.S. subsidiary.
"We have been committed to patient care and medical innovation since day
one and our vision of providing patients with the safest, highest quality human protein therapies available is stronger than ever," said Octapharma US...
R-Tech Ueno, Ltd. Completes Phase 1 Clinical Study on RK-023
... 6 and 2 out of 8 healthy adult males respectively. No serious adverse event was observed during the total 9 times of application up to the morning of day
5. When the drug concentration in the blood was measured, the level was below the quantification limit as in the case of the single-dose study.
Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus
groups, versus placebo, had their average prednisone dose
reduced by at least 25% from baseline to 7.5 mg per day
during the last 12 weeks of study (p=0.053 for 10 mg/kg and
p=0.025 for 1 mg/kg belimumab, respectively vs. placeb...
BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza
...efficacy and safety of a single dose of peramivir (either 300 mg or 600 mg) and treatment with oral oseltamivir phosphate 75 mg (Tamiflu((R))) twice a day
for five days. A total of 1,099 patients were enrolled at 146 centers (Japan:100; Korea:25; Taiwan:21). Both the 300 mg and 600 mg single dose perami...
Reliv International's GlucAffect(TM) Proven Effective in Clinical Study
The participants consumed GlucAffect or a placebo product four times a day
for six days a week, participated in an exercise program and ate a healthy diet. They didn't follow the study regimen on the seventh day
of the week.
"GlucAffect is formulated with a unique combination o...
Analysis of Edoxaban Phase II Data Provides Insight Into Reduced Bleeding Events Seen in Once-Daily Dosing
...eeding events than patients given edoxaban twice a day
(BID). The analysis finds that bleeding associated...the curve or AUC). Delivering a compound twice per day
generally allows for more consistent concentration...efore dosing and one to three hours post-dosing on day
28. The relationship between PK and all bleeding e...
Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center
...to 6 patients at each dose level. All patients will receive perifosine at a loading dose on the first day, followed by a maintenance dose to start on day
two until progression of disease. A minimum of 4 and a maximum of 24 patients will be required to complete the study.
KRX-0401 (perifosine) is...
University of Michigan Study Shows SEQUENOM's MassARRAY Technology Identifies HPV Infections Missed by Standard Hybridization Test
...icted a HPV DNA test capable of genotyping and quantifying HPV DNA will one day
supplant the Pap smear as the primary screening test for cervical cancer. ...ether a HPV DNA test capable of genotyping and quantifying HPV DNA will one day
supplant the Pap smear as the primary screening test for cervical cancer, t...
PTSD Associated With Higher Alzheimer's/Dementia Risk; Moderate Alcohol Consumption May Lower it
...d. "However, this does not appear to be true for those who already have mild cognitive impairment. Current recommendations not to exceed one drink per day
for women and two for men are supported by these results."
About ICAD 2009
The 2009 Alzheimer's Association International Confer...
Results From Trials of DHA in Alzheimer's Disease and Age-Related Cognitive Decline
...r day. Subjects were treated with DHA or placebo at a dose of two grams per day
for 18 months. Those participants already taking approved Alzheimer's drugs...olled, multi-center, six month study to determine the effects of 900 mg per day
of algal DHA on improving cognitive functions in 485 healthy older people (...
Dry Mouth Linked to Prescription and Over the Counter Drugs
...uss symptoms with their dentist, even if they do not experience them on the day
of the office visit."
The AGD reports a number of actions dry mouth s...ke to alleviate the condition:
Brush and floss twice a day
Chew sugarless gum or suck on non-citrus flavored or sour sugarless...
Orkin Warns of Four Pests to Avoid this Fourth of July
... ATLANTA, June 30 /PRNewswire/ -- As Americans celebrate Independence day
outdoors, pest control giant Orkin, Inc., warns about the four common pests that are most likely to crash the holiday festivities: mosquitoes, ticks, ...
BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic Dermatitis
...was superior to placebo in
decreasing skin redness and improving skin barrier function. Statistically
significant improvement was observed as early as day
10 after begining
treatment. There was also a significant improvement in EASI score over the
whole treatment period for ProtoCure emulsion cream as a ...
Alfacell Provides Shareholder Update
...iving those patients debilitated by these dreadful cancers the opportunity to live meaningful lives while we continue to find better therapies and one day
a permanent cure for cancer.
President, Chief Operating Officer
ONCONASE is a first...
Neurocrine Biosciences Presents Elagolix Data
...s of elagolix. The results of this study showed that daily administration of elagolix induced partial suppression of gonadotropins for 12-18 hours per day
with a return to baseline each morning for 42 days. The effect on gonadotropins translated in a dose related fashion to maintenance of low estradiol l...
MacroGenics and Lilly Achieve Targeted Patient Enrollment in PROTEGE, a Global Phase 2/3 Clinical Trial of Teplizumab in Type 1 Diabetes
... childhood and adolescence, the disease can strike adults as well. Individuals with type 1 diabetes must test their blood sugar four or more times per day
and take multiple insulin injections daily or continually infuse insulin through a pump. While trying to balance insulin doses with their food intake ...
Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily
Patients were randomized in groups and received one of five treatments, tadalafil 2.5 mg, 10 mg, 20 mg, 40 mg or placebo, orally once a day
as monotherapy or as add-on therapy to bosentan. The primary endpoint was change from baseline to Week 16 in six-minute walk distance (6MWD)(2). Demog...
DOR BioPharma Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec(R) in GI GVHD
...ry endpoint is the treatment failure rate at Study day
80. This endpoint was successfully measured as a ...y endpoint of the 'treatment failure rate at Study day
80,' we expect to replicate statistical significan...l, namely median time-to-treatment failure through day
50 (p-value 0.1177), orBec(R) did achieve statisti...
ISTA Pharmaceuticals Announces Positive Results for Phase 2 Study of Low-Dose Bromfenac in Dry Eye Disease
...ts received low-dose bromfenac bilaterally twice a day
for 42 days. Patient baseline scores were recorde...ow-dose bromfenac and were compared to baseline at day
Micromet Presents Update on Blinatumomab's Response Rate and Duration in a Phase 1 Study in Non-Hodgkin's Lymphoma Patients
... show that 11 out of 12 patients having received a dose of 0.06 mg/m(2) per day
during the first treatment cycle have responded according to standard Ches...e free interval of 13 months for the seven patients in the 0.06 mg/m(2) per day
dose cohort reported at ASH in 2008(2). The most common adverse events (AEs...
Afinitor(R) Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma, Leading to Phase III Trial
...ic lymphoma (18% ORR)(1).
Patients received everolimus 10 mg daily and were evaluated monthly. Dose reductions to 5 mg daily and 5 mg every other day
were permitted. Response was assessed after two cycles of treatment and periodically thereafter. Patients received a median of three cycles(1). Overal...
Heaviest Smokers Face Greatest Risk of Death After Lung Cancer Diagnosis
... and how much a person smoked - have found that smoking intensity in fact predicts how the disease will progress.
Patients who smoked two packs a day
had a 58 percent higher risk of their lung cancers returning or spreading compared with nonsmoking patients.
Smoking intensity is one of only two...
CEL SCI Collaborators Demonstrate Novel L.E.A.P.S. Vaccines Immunize Mice Against Tuberculosis Antigens and Suggest Potential to Treat Swine and Other Influenzas
...d at the Microbiology Conference that mouse blood cells taken from L.E.A.P.S. TB immunized mice made detectable amounts of gamma interferon within one day
Dr. Daniel Zimmerman, the inventor of the technology believes that the data presented by Dr. Borthakur's group will also be benefi...